Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Miceli

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
ESMO Open|March 20, 2021
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapyE Ortolan, V Appierto, M Silvestri, et al.
Tumori|April 4, 1998
Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrualG De Palo, T Camerini, E Marubini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancerS Cavalieri, F Perrone, R Miceli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
Tumori|January 24, 2026
Medical decision analysis for personalized oncology at the patient bedsideP G Casali, L Licitra, S Provenzano, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
Journal of the National Cancer Institute|November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerU Veronesi, G De Palo, E Marubini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogramF Pietrantonio, R Miceli, L Rimassa, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE studyP Andena, G Tine, F Nichetti, et al.
BMC Public Health|December 19, 2024
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European surveyG Apolone, M Costantini, L Caselli, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
ESMO Open|March 20, 2021
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapyE Ortolan, V Appierto, M Silvestri, et al.
Tumori|April 4, 1998
Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrualG De Palo, T Camerini, E Marubini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancerS Cavalieri, F Perrone, R Miceli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
Tumori|January 24, 2026
Medical decision analysis for personalized oncology at the patient bedsideP G Casali, L Licitra, S Provenzano, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
Journal of the National Cancer Institute|November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerU Veronesi, G De Palo, E Marubini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogramF Pietrantonio, R Miceli, L Rimassa, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE studyP Andena, G Tine, F Nichetti, et al.
BMC Public Health|December 19, 2024
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European surveyG Apolone, M Costantini, L Caselli, et al.
Pageof 10